Thymidine Labeling Index in Breast Cancer Prognosis
- 1 January 1998
- journal article
- Published by Hindawi Limited in The Breast Journal
- Vol. 4 (1) , 41-48
- https://doi.org/10.1046/j.1524-4741.1998.410041.x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- S-phase fraction and nuclear size in long term prognosis of patients with breast cancerCancer, 1994
- Cell kinetics as a predictive factor in node-positive breast cancer treated with adjuvant hormone therapy.Journal of Clinical Oncology, 1993
- Bromodeoxyuridine labeling for S-phase measurement in breast carcinomaCancer, 1993
- Natural history of human breast cancer: Recent data and clinical implicationsBreast Cancer Research and Treatment, 1991
- Proliferative index of breast carcinoma by thymidine labeling: Prognostic power independent of stage, estrogen and progesterone receptorsBreast Cancer Research and Treatment, 1988
- Cell kinetics as a prognostic marker in node-negative breast cancerCancer, 1985
- The long‐term prognostic significance of the thymidine labelling index in breast cancerInternational Journal of Cancer, 1984
- Prediction of early course of breast carcinoma by thymidine labelingCancer, 1983
- Cell proliferation and its relationship to clinical features and relapse in breast cancersCancer, 1981
- Relationship between proliferative activity and estrogen receptors in breast cancerCancer, 1979